SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Pharma - Quaterly Results

10 Aug 2023 Evaluate
The sales moved up 39.65% to Rs. 1829.20 millions for the June 2023 quarter as compared to Rs. 1309.88 millions during the year-ago period.The Total Profit for the quarter ended June 2023 of Rs. 107.75 millions grew from Rs.-140.88 millionsThe company reported a good operating profit of 240.28 millions compared to 153.81 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1829.20 1309.88 39.65 1829.20 1309.88 39.65 6658.98 5569.74 19.56
Other Income 18.86 29.31 -35.65 18.86 29.31 -35.65 194.31 90.03 115.83
PBIDT 240.28 153.81 56.22 240.28 153.81 56.22 1030.49 662.62 55.52
Interest 55.45 78.40 -29.27 55.45 78.40 -29.27 322.26 320.12 0.67
PBDT 184.83 75.41 145.10 184.83 75.41 145.10 1100.33 342.50 221.26
Depreciation 77.08 216.29 -64.36 77.08 216.29 -64.36 547.86 870.21 -37.04
PBT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 107.75 -140.88 -176.48 107.75 -140.88 -176.48 552.47 -527.71 -204.69
Equity 507.19 408.16 24.26 507.19 408.16 24.26 408.16 408.16 0.00
PBIDTM(%) 13.14 11.74 11.87 13.14 11.74 11.87 15.48 11.90 30.08

Orchid Pharma Share Price

564.10 -3.40 (-0.60%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×